| pubmed-article:11785694 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11785694 | lifeskim:mentions | umls-concept:C0012655 | lld:lifeskim |
| pubmed-article:11785694 | lifeskim:mentions | umls-concept:C0021853 | lld:lifeskim |
| pubmed-article:11785694 | lifeskim:mentions | umls-concept:C0031164 | lld:lifeskim |
| pubmed-article:11785694 | lifeskim:mentions | umls-concept:C0220807 | lld:lifeskim |
| pubmed-article:11785694 | lifeskim:mentions | umls-concept:C0301624 | lld:lifeskim |
| pubmed-article:11785694 | lifeskim:mentions | umls-concept:C2267054 | lld:lifeskim |
| pubmed-article:11785694 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:11785694 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:11785694 | pubmed:dateCreated | 2002-1-10 | lld:pubmed |
| pubmed-article:11785694 | pubmed:abstractText | To study the in vitro intestinal permeability of a number of newly synthesised factor Xa inhibitors to better understand the poor oral absorption of these compounds. | lld:pubmed |
| pubmed-article:11785694 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11785694 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11785694 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11785694 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11785694 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11785694 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11785694 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:11785694 | pubmed:issn | 0724-8741 | lld:pubmed |
| pubmed-article:11785694 | pubmed:author | pubmed-author:OsterbergTT | lld:pubmed |
| pubmed-article:11785694 | pubmed:author | pubmed-author:SjöströmBB | lld:pubmed |
| pubmed-article:11785694 | pubmed:author | pubmed-author:YoungWW | lld:pubmed |
| pubmed-article:11785694 | pubmed:author | pubmed-author:SokolowskiAA | lld:pubmed |
| pubmed-article:11785694 | pubmed:author | pubmed-author:RajSS | lld:pubmed |
| pubmed-article:11785694 | pubmed:author | pubmed-author:SchipperN GNG | lld:pubmed |
| pubmed-article:11785694 | pubmed:author | pubmed-author:WestbergCC | lld:pubmed |
| pubmed-article:11785694 | pubmed:author | pubmed-author:WrangeUU | lld:pubmed |
| pubmed-article:11785694 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11785694 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:11785694 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11785694 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11785694 | pubmed:pagination | 1735-41 | lld:pubmed |
| pubmed-article:11785694 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:11785694 | pubmed:meshHeading | pubmed-meshheading:11785694... | lld:pubmed |
| pubmed-article:11785694 | pubmed:meshHeading | pubmed-meshheading:11785694... | lld:pubmed |
| pubmed-article:11785694 | pubmed:meshHeading | pubmed-meshheading:11785694... | lld:pubmed |
| pubmed-article:11785694 | pubmed:meshHeading | pubmed-meshheading:11785694... | lld:pubmed |
| pubmed-article:11785694 | pubmed:meshHeading | pubmed-meshheading:11785694... | lld:pubmed |
| pubmed-article:11785694 | pubmed:meshHeading | pubmed-meshheading:11785694... | lld:pubmed |
| pubmed-article:11785694 | pubmed:meshHeading | pubmed-meshheading:11785694... | lld:pubmed |
| pubmed-article:11785694 | pubmed:meshHeading | pubmed-meshheading:11785694... | lld:pubmed |
| pubmed-article:11785694 | pubmed:meshHeading | pubmed-meshheading:11785694... | lld:pubmed |
| pubmed-article:11785694 | pubmed:meshHeading | pubmed-meshheading:11785694... | lld:pubmed |
| pubmed-article:11785694 | pubmed:meshHeading | pubmed-meshheading:11785694... | lld:pubmed |
| pubmed-article:11785694 | pubmed:meshHeading | pubmed-meshheading:11785694... | lld:pubmed |
| pubmed-article:11785694 | pubmed:meshHeading | pubmed-meshheading:11785694... | lld:pubmed |
| pubmed-article:11785694 | pubmed:meshHeading | pubmed-meshheading:11785694... | lld:pubmed |
| pubmed-article:11785694 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11785694 | pubmed:articleTitle | In vitro intestinal permeability of factor Xa inhibitors: influence of chemical structure on passive transport and susceptibility to efflux. | lld:pubmed |
| pubmed-article:11785694 | pubmed:affiliation | Pharmacia Corporation, Division Biovitrum, Stockholm, Sweden. | lld:pubmed |
| pubmed-article:11785694 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11785694 | lld:pubmed |
